Joseph Alcorn

Joseph Alcorn is a Researcher specializing in substance abuse and pharmacotherapy. His work focuses on clinical psychopharmacology, particularly drug combinations for treating methamphetamine-use disorder and cannabis-related behaviors.

• Affiliation: Substance Use Priority Research Area
• Expertise: Neuropsychopharmacology, Behavioral Science, Clinical Research

In 2021, he co-authored a study in Experimental and Clinical Psychopharmacology on pregabalin maintenance in daily cannabis users, highlighting his interest in pharmacological interventions for substance use disorders. His research output aligns with clinical studies and behavioral neuroscience.

• Key Collaborator: National Institute on Drug Abuse (2019–2021)
• h-index: 3 (based on citations from PlumX and Pure)